Using inhibitors of ATM, such as KU60019, ultimately restored levels of LARP7, SIRT1 and mitochondrial biogenesis preventing adverse remodeling effects of myocardial infarction (MI). This evidence concerns the gene SIRT1 and myocardial infarction.